We are live on ! Find out more
RPTX

Repare Therapeutics
RPTX

Delisted

RPTX was delisted on the 27th of January, 2026.

Back to rankings

0 hedge funds and large institutions have $0 invested in Repare Therapeutics in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 45 closing their positions.

New
Increased
Maintained
Reduced
Closed

58.37% less ownership

Funds ownership: 58.37% → 0% (-58%)

100% less funds holding

Funds holding: 46 → 0 (-46)

100% less funds holding in top 10

Funds holding in top 10: 4 → 0 (-4)

100% less capital invested

Capital invested by funds: $65.4M → $0 (-$65.4M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 45

Holders
–
Holders Change
-46
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
45
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$26.9M
2
BOCH
Blue Owl Capital Holdings
New York
-$8.95M
3
O
OrbiMed
New York
-$8.64M
4
RG
Redmile Group
California
-$4.12M
5
RC
Rangeley Capital
Connecticut
-$3.35M
Name Holding Trade Value Shares
Change 		Change in
Stake
BI
1
BVF Inc
California
– -$26.9M -10,333,600 Closed
BOCH
2
Blue Owl Capital Holdings
New York
– -$8.95M -3,443,659 Closed
O
3
OrbiMed
New York
– -$8.64M -3,322,488 Closed
RG
4
Redmile Group
California
– -$4.12M -1,586,174 Closed
RC
5
Rangeley Capital
Connecticut
– -$3.35M -1,287,829 Closed
Marshall Wace
6
Marshall Wace
United Kingdom
– -$2.9M -1,115,744 Closed
Renaissance Technologies
7
Renaissance Technologies
New York
– -$2.55M -981,360 Closed
Acadian Asset Management
8
Acadian Asset Management
Massachusetts
– -$1.61M -618,672 Closed
Two Sigma Investments
9
Two Sigma Investments
New York
– -$868K -333,694 Closed
Jane Street
10
Jane Street
New York
– -$724K -278,304 Closed
YCM
11
Yakira Capital Management
Connecticut
– -$693K -266,601 Closed
Northern Trust
12
Northern Trust
Illinois
– -$677K -260,311 Closed
Citadel Advisors
13
Citadel Advisors
Florida
– -$621K -238,912 Closed
BlackRock
14
BlackRock
New York
– -$375K -144,219 Closed
EPM
15
Equitec Proprietary Markets
Illinois
– -$308K -118,375 Closed
XT
16
XTX Topco
Cayman Islands
– -$304K -116,933 Closed
Walleye Capital
17
Walleye Capital
New York
– -$277K -106,683 Closed
Bank of Montreal
18
Bank of Montreal
Ontario, Canada
– -$273K -104,919 Closed
Two Sigma Advisers
19
Two Sigma Advisers
New York
– -$141K -54,200 Closed
Point72 Asset Management
20
Point72 Asset Management
Connecticut
– -$133K -51,252 Closed
HF
21
HRT Financial
New York
– -$109K -42,301 Closed
QOP
22
Quinn Opportunity Partners
Virginia
– -$104K -40,000 Closed
FIA
23
FNY Investment Advisers
New York
– -$91K -35,000 Closed
NW
24
NewEdge Wealth
Pennsylvania
– -$85.7K -32,959 Closed
VF
25
Virtu Financial
New York
– -$40K -15,488 Closed
1
2

RPTX Hedge Fund Activity: Q1 2026 in Review

0 of the 8,134 institutional investors tracked by Wall St. Rank reported a position in Repare Therapeutics (RPTX) for Q1 2026, worth a combined $0 — down 100% from $65.4M a quarter earlier.

Sellers outnumbered buyers: 45 funds closed out of RPTX and 0 opened new positions — a net loss of 45 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BVF Inc, exiting entirely with an estimated $26.9M sold.

  • 0 institutional investors held Repare Therapeutics (RPTX) as of Q1 2026, down from 46 in Q4 2025.
  • Funds reported $0 of Repare Therapeutics stock for Q1 2026, down 100% quarter-over-quarter.
  • 0 funds opened new Repare Therapeutics positions in Q1 2026 and 45 closed out, a net change of -45 holders.
  • The largest Repare Therapeutics seller in Q1 2026 was BVF Inc, an estimated $26.9M sold.

Based on aggregated 13F filings for Q1 2026.